この調査では、テクノロジーと科学研究の進歩が、今後数年間にアメリカの臨床試験市場の成長を促進する主な理由の 1 つであることが特定されています。 また、臨床試験プロセスのアウトソーシングの増加とヘルスケアおよび製薬産業への投資の増加により、市場での相当な需要が増加すると予想されます。
また、このレポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。
このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Country Market Characteristics
Exhibit 04: Executive Summary - Chart on Market Segmentation by Type
Exhibit 05: Executive Summary - Chart on Market Segmentation by Service Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Indication
Exhibit 07: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 08: Parent market
Exhibit 09: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 10: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 11: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 12: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 13: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 14: Chart on US: Year-over-year growth 2022-2027 (%)
Exhibit 15: Data Table on US: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Clinical trials market in US 2017 - 2021
Exhibit 16: Historic Market Size - Data Table on clinical trials market in US 2017 - 2021 ($ billion)
4.2 Type Segment Analysis 2017 - 2021
Exhibit 17: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
4.3 Service Type Segment Analysis 2017 - 2021
Exhibit 18: Historic Market Size - Service Type Segment 2017 - 2021 ($ billion)
4.4 Indication Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Indication Segment 2017 - 2021 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 20: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 21: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 22: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 23: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 24: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 25: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 26: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Type
6.1 Market segments
Exhibit 27: Chart on Type - Market share 2022-2027 (%)
Exhibit 28: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 29: Chart on Comparison by Type
Exhibit 30: Data Table on Comparison by Type
6.3 Phase III - Market size and forecast 2022-2027
Exhibit 31: Chart on Phase III - Market size and forecast 2022-2027 ($ billion)
Exhibit 32: Data Table on Phase III - Market size and forecast 2022-2027 ($ billion)
Exhibit 33: Chart on Phase III - Year-over-year growth 2022-2027 (%)
Exhibit 34: Data Table on Phase III - Year-over-year growth 2022-2027 (%)
6.4 Phase I - Market size and forecast 2022-2027
Exhibit 35: Chart on Phase I - Market size and forecast 2022-2027 ($ billion)
Exhibit 36: Data Table on Phase I - Market size and forecast 2022-2027 ($ billion)
Exhibit 37: Chart on Phase I - Year-over-year growth 2022-2027 (%)
Exhibit 38: Data Table on Phase I - Year-over-year growth 2022-2027 (%)
6.5 Phase II - Market size and forecast 2022-2027
Exhibit 39: Chart on Phase II - Market size and forecast 2022-2027 ($ billion)
Exhibit 40: Data Table on Phase II - Market size and forecast 2022-2027 ($ billion)
Exhibit 41: Chart on Phase II - Year-over-year growth 2022-2027 (%)
Exhibit 42: Data Table on Phase II - Year-over-year growth 2022-2027 (%)
6.6 Phase IV - Market size and forecast 2022-2027
Exhibit 43: Chart on Phase IV - Market size and forecast 2022-2027 ($ billion)
Exhibit 44: Data Table on Phase IV - Market size and forecast 2022-2027 ($ billion)
Exhibit 45: Chart on Phase IV - Year-over-year growth 2022-2027 (%)
Exhibit 46: Data Table on Phase IV - Year-over-year growth 2022-2027 (%)
6.7 Market opportunity by Type
Exhibit 47: Market opportunity by Type ($ billion)
Exhibit 48: Data Table on Market opportunity by Type ($ billion)
7 Market Segmentation by Service Type
7.1 Market segments
Exhibit 49: Chart on Service Type - Market share 2022-2027 (%)
Exhibit 50: Data Table on Service Type - Market share 2022-2027 (%)
7.2 Comparison by Service Type
Exhibit 51: Chart on Comparison by Service Type
Exhibit 52: Data Table on Comparison by Service Type
7.3 Interventional studies - Market size and forecast 2022-2027
Exhibit 53: Chart on Interventional studies - Market size and forecast 2022-2027 ($ billion)
Exhibit 54: Data Table on Interventional studies - Market size and forecast 2022-2027 ($ billion)
Exhibit 55: Chart on Interventional studies - Year-over-year growth 2022-2027 (%)
Exhibit 56: Data Table on Interventional studies - Year-over-year growth 2022-2027 (%)
7.4 Observational studies - Market size and forecast 2022-2027
Exhibit 57: Chart on Observational studies - Market size and forecast 2022-2027 ($ billion)
Exhibit 58: Data Table on Observational studies - Market size and forecast 2022-2027 ($ billion)
Exhibit 59: Chart on Observational studies - Year-over-year growth 2022-2027 (%)
Exhibit 60: Data Table on Observational studies - Year-over-year growth 2022-2027 (%)
7.5 Expanded access studies - Market size and forecast 2022-2027
Exhibit 61: Chart on Expanded access studies - Market size and forecast 2022-2027 ($ billion)
Exhibit 62: Data Table on Expanded access studies - Market size and forecast 2022-2027 ($ billion)
Exhibit 63: Chart on Expanded access studies - Year-over-year growth 2022-2027 (%)
Exhibit 64: Data Table on Expanded access studies - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Service Type
Exhibit 65: Market opportunity by Service Type ($ billion)
Exhibit 66: Data Table on Market opportunity by Service Type ($ billion)
8 Market Segmentation by Indication
8.1 Market segments
Exhibit 67: Chart on Indication - Market share 2022-2027 (%)
Exhibit 68: Data Table on Indication - Market share 2022-2027 (%)
8.2 Comparison by Indication
Exhibit 69: Chart on Comparison by Indication
Exhibit 70: Data Table on Comparison by Indication
8.3 Oncology - Market size and forecast 2022-2027
Exhibit 71: Chart on Oncology - Market size and forecast 2022-2027 ($ billion)
Exhibit 72: Data Table on Oncology - Market size and forecast 2022-2027 ($ billion)
Exhibit 73: Chart on Oncology - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
8.4 CNS - Market size and forecast 2022-2027
Exhibit 75: Chart on CNS - Market size and forecast 2022-2027 ($ billion)
Exhibit 76: Data Table on CNS - Market size and forecast 2022-2027 ($ billion)
Exhibit 77: Chart on CNS - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on CNS - Year-over-year growth 2022-2027 (%)
8.5 Autoimmune/inflammation - Market size and forecast 2022-2027
Exhibit 79: Chart on Autoimmune/inflammation - Market size and forecast 2022-2027 ($ billion)
Exhibit 80: Data Table on Autoimmune/inflammation - Market size and forecast 2022-2027 ($ billion)
Exhibit 81: Chart on Autoimmune/inflammation - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Autoimmune/inflammation - Year-over-year growth 2022-2027 (%)
8.6 Cardiovascular and others - Market size and forecast 2022-2027
Exhibit 83: Chart on Cardiovascular and others - Market size and forecast 2022-2027 ($ billion)
Exhibit 84: Data Table on Cardiovascular and others - Market size and forecast 2022-2027 ($ billion)
Exhibit 85: Chart on Cardiovascular and others - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Cardiovascular and others - Year-over-year growth 2022-2027 (%)
8.7 Market opportunity by Indication
Exhibit 87: Market opportunity by Indication ($ billion)
Exhibit 88: Data Table on Market opportunity by Indication ($ billion)
9 Customer Landscape
9.1 Customer landscape overview
Exhibit 89: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 90: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 91: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 92: Overview on factors of disruption
11.4 Industry risks
Exhibit 93: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 94: Vendors covered
12.2 Market positioning of vendors
Exhibit 95: Matrix on vendor position and classification
12.3 Accell Clinical Research LLC
Exhibit 96: Accell Clinical Research LLC - Overview
Exhibit 97: Accell Clinical Research LLC - Key offerings
12.4 Caidya
Exhibit 98: Caidya - Overview
Exhibit 99: Caidya - Key offerings
12.5 Charles River Laboratories International Inc.
Exhibit 100: Charles River Laboratories International Inc. - Overview
Exhibit 101: Charles River Laboratories International Inc. - Business segments
Exhibit 102: Charles River Laboratories International Inc. - Key news
Exhibit 103: Charles River Laboratories International Inc. - Key offerings
Exhibit 104: Charles River Laboratories International Inc. - Segment focus
12.6 Clinipace Inc.
Exhibit 105: Clinipace Inc. - Overview
Exhibit 106: Clinipace Inc. - Product / Service
Exhibit 107: Clinipace Inc. - Key offerings
12.7 CTI Clinical Trial and Consulting Inc.
Exhibit 108: CTI Clinical Trial and Consulting Inc. - Overview
Exhibit 109: CTI Clinical Trial and Consulting Inc. - Product / Service
Exhibit 110: CTI Clinical Trial and Consulting Inc. - Key offerings
12.8 Eli Lilly and Co.
Exhibit 111: Eli Lilly and Co. - Overview
Exhibit 112: Eli Lilly and Co. - Product / Service
Exhibit 113: Eli Lilly and Co. - Key news
Exhibit 114: Eli Lilly and Co. - Key offerings
12.9 ICON plc
Exhibit 115: ICON plc - Overview
Exhibit 116: ICON plc - Product / Service
Exhibit 117: ICON plc - Key offerings
12.10 IQVIA Holdings Inc.
Exhibit 118: IQVIA Holdings Inc. - Overview
Exhibit 119: IQVIA Holdings Inc. - Business segments
Exhibit 120: IQVIA Holdings Inc. - Key news
Exhibit 121: IQVIA Holdings Inc. - Key offerings
Exhibit 122: IQVIA Holdings Inc. - Segment focus
12.11 Laboratory Corp. of America Holdings
Exhibit 123: Laboratory Corp. of America Holdings - Overview
Exhibit 124: Laboratory Corp. of America Holdings - Business segments
Exhibit 125: Laboratory Corp. of America Holdings - Key news
Exhibit 126: Laboratory Corp. of America Holdings - Key offerings
Exhibit 127: Laboratory Corp. of America Holdings - Segment focus
12.12 Medpace Holdings Inc.
Exhibit 128: Medpace Holdings Inc. - Overview
Exhibit 129: Medpace Holdings Inc. - Product / Service
Exhibit 130: Medpace Holdings Inc. - Key offerings
12.13 Parexel International Corp.
Exhibit 131: Parexel International Corp. - Overview
Exhibit 132: Parexel International Corp. - Product / Service
Exhibit 133: Parexel International Corp. - Key news
Exhibit 134: Parexel International Corp. - Key offerings
12.14 Pfizer Inc.
Exhibit 135: Pfizer Inc. - Overview
Exhibit 136: Pfizer Inc. - Product / Service
Exhibit 137: Pfizer Inc. - Key news
Exhibit 138: Pfizer Inc. - Key offerings
12.15 Sanofi
Exhibit 139: Sanofi - Overview
Exhibit 140: Sanofi - Business segments
Exhibit 141: Sanofi - Key news
Exhibit 142: Sanofi - Key offerings
Exhibit 143: Sanofi - Segment focus
12.16 Syneos Health Inc.
Exhibit 144: Syneos Health Inc. - Overview
Exhibit 145: Syneos Health Inc. - Business segments
Exhibit 146: Syneos Health Inc. - Key offerings
Exhibit 147: Syneos Health Inc. - Segment focus
12.17 Thermo Fisher Scientific Inc.
Exhibit 148: Thermo Fisher Scientific Inc. - Overview
Exhibit 149: Thermo Fisher Scientific Inc. - Business segments
Exhibit 150: Thermo Fisher Scientific Inc. - Key news
Exhibit 151: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 152: Thermo Fisher Scientific Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 153: Inclusions checklist
Exhibit 154: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 155: Currency conversion rates for US$
13.4 Research methodology
Exhibit 156: Research methodology
Exhibit 157: Validation techniques employed for market sizing
Exhibit 158: Information sources
13.5 List of abbreviations
Exhibit 159: List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Country Market Characteristics
Exhibits4: Executive Summary - Chart on Market Segmentation by Type
Exhibits5: Executive Summary - Chart on Market Segmentation by Service Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Indication
Exhibits7: Executive Summary - Chart on Vendor Market Positioning
Exhibits8: Parent market
Exhibits9: Market Characteristics
Exhibits10: Offerings of vendors included in the market definition
Exhibits11: Market segments
Exhibits12: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits13: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits14: Chart on US: Year-over-year growth 2022-2027 (%)
Exhibits15: Data Table on US: Year-over-year growth 2022-2027 (%)
Exhibits16: Historic Market Size - Data Table on clinical trials market in US 2017 - 2021 ($ billion)
Exhibits17: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
Exhibits18: Historic Market Size - Service Type Segment 2017 - 2021 ($ billion)
Exhibits19: Historic Market Size - Indication Segment 2017 - 2021 ($ billion)
Exhibits20: Five forces analysis - Comparison between 2022 and 2027
Exhibits21: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits22: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits23: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits24: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits25: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits26: Chart on Market condition - Five forces 2022 and 2027
Exhibits27: Chart on Type - Market share 2022-2027 (%)
Exhibits28: Data Table on Type - Market share 2022-2027 (%)
Exhibits29: Chart on Comparison by Type
Exhibits30: Data Table on Comparison by Type
Exhibits31: Chart on Phase III - Market size and forecast 2022-2027 ($ billion)
Exhibits32: Data Table on Phase III - Market size and forecast 2022-2027 ($ billion)
Exhibits33: Chart on Phase III - Year-over-year growth 2022-2027 (%)
Exhibits34: Data Table on Phase III - Year-over-year growth 2022-2027 (%)
Exhibits35: Chart on Phase I - Market size and forecast 2022-2027 ($ billion)
Exhibits36: Data Table on Phase I - Market size and forecast 2022-2027 ($ billion)
Exhibits37: Chart on Phase I - Year-over-year growth 2022-2027 (%)
Exhibits38: Data Table on Phase I - Year-over-year growth 2022-2027 (%)
Exhibits39: Chart on Phase II - Market size and forecast 2022-2027 ($ billion)
Exhibits40: Data Table on Phase II - Market size and forecast 2022-2027 ($ billion)
Exhibits41: Chart on Phase II - Year-over-year growth 2022-2027 (%)
Exhibits42: Data Table on Phase II - Year-over-year growth 2022-2027 (%)
Exhibits43: Chart on Phase IV - Market size and forecast 2022-2027 ($ billion)
Exhibits44: Data Table on Phase IV - Market size and forecast 2022-2027 ($ billion)
Exhibits45: Chart on Phase IV - Year-over-year growth 2022-2027 (%)
Exhibits46: Data Table on Phase IV - Year-over-year growth 2022-2027 (%)
Exhibits47: Market opportunity by Type ($ billion)
Exhibits48: Data Table on Market opportunity by Type ($ billion)
Exhibits49: Chart on Service Type - Market share 2022-2027 (%)
Exhibits50: Data Table on Service Type - Market share 2022-2027 (%)
Exhibits51: Chart on Comparison by Service Type
Exhibits52: Data Table on Comparison by Service Type
Exhibits53: Chart on Interventional studies - Market size and forecast 2022-2027 ($ billion)
Exhibits54: Data Table on Interventional studies - Market size and forecast 2022-2027 ($ billion)
Exhibits55: Chart on Interventional studies - Year-over-year growth 2022-2027 (%)
Exhibits56: Data Table on Interventional studies - Year-over-year growth 2022-2027 (%)
Exhibits57: Chart on Observational studies - Market size and forecast 2022-2027 ($ billion)
Exhibits58: Data Table on Observational studies - Market size and forecast 2022-2027 ($ billion)
Exhibits59: Chart on Observational studies - Year-over-year growth 2022-2027 (%)
Exhibits60: Data Table on Observational studies - Year-over-year growth 2022-2027 (%)
Exhibits61: Chart on Expanded access studies - Market size and forecast 2022-2027 ($ billion)
Exhibits62: Data Table on Expanded access studies - Market size and forecast 2022-2027 ($ billion)
Exhibits63: Chart on Expanded access studies - Year-over-year growth 2022-2027 (%)
Exhibits64: Data Table on Expanded access studies - Year-over-year growth 2022-2027 (%)
Exhibits65: Market opportunity by Service Type ($ billion)
Exhibits66: Data Table on Market opportunity by Service Type ($ billion)
Exhibits67: Chart on Indication - Market share 2022-2027 (%)
Exhibits68: Data Table on Indication - Market share 2022-2027 (%)
Exhibits69: Chart on Comparison by Indication
Exhibits70: Data Table on Comparison by Indication
Exhibits71: Chart on Oncology - Market size and forecast 2022-2027 ($ billion)
Exhibits72: Data Table on Oncology - Market size and forecast 2022-2027 ($ billion)
Exhibits73: Chart on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on CNS - Market size and forecast 2022-2027 ($ billion)
Exhibits76: Data Table on CNS - Market size and forecast 2022-2027 ($ billion)
Exhibits77: Chart on CNS - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on CNS - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Autoimmune/inflammation - Market size and forecast 2022-2027 ($ billion)
Exhibits80: Data Table on Autoimmune/inflammation - Market size and forecast 2022-2027 ($ billion)
Exhibits81: Chart on Autoimmune/inflammation - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Autoimmune/inflammation - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Cardiovascular and others - Market size and forecast 2022-2027 ($ billion)
Exhibits84: Data Table on Cardiovascular and others - Market size and forecast 2022-2027 ($ billion)
Exhibits85: Chart on Cardiovascular and others - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Cardiovascular and others - Year-over-year growth 2022-2027 (%)
Exhibits87: Market opportunity by Indication ($ billion)
Exhibits88: Data Table on Market opportunity by Indication ($ billion)
Exhibits89: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits90: Impact of drivers and challenges in 2022 and 2027
Exhibits91: Overview on Criticality of inputs and Factors of differentiation
Exhibits92: Overview on factors of disruption
Exhibits93: Impact of key risks on business
Exhibits94: Vendors covered
Exhibits95: Matrix on vendor position and classification
Exhibits96: Accell Clinical Research LLC - Overview
Exhibits97: Accell Clinical Research LLC - Key offerings
Exhibits98: Caidya - Overview
Exhibits99: Caidya - Key offerings
Exhibits100: Charles River Laboratories International Inc. - Overview
Exhibits101: Charles River Laboratories International Inc. - Business segments
Exhibits102: Charles River Laboratories International Inc. - Key news
Exhibits103: Charles River Laboratories International Inc. - Key offerings
Exhibits104: Charles River Laboratories International Inc. - Segment focus
Exhibits105: Clinipace Inc. - Overview
Exhibits106: Clinipace Inc. - Product / Service
Exhibits107: Clinipace Inc. - Key offerings
Exhibits108: CTI Clinical Trial and Consulting Inc. - Overview
Exhibits109: CTI Clinical Trial and Consulting Inc. - Product / Service
Exhibits110: CTI Clinical Trial and Consulting Inc. - Key offerings
Exhibits111: Eli Lilly and Co. - Overview
Exhibits112: Eli Lilly and Co. - Product / Service
Exhibits113: Eli Lilly and Co. - Key news
Exhibits114: Eli Lilly and Co. - Key offerings
Exhibits115: ICON plc - Overview
Exhibits116: ICON plc - Product / Service
Exhibits117: ICON plc - Key offerings
Exhibits118: IQVIA Holdings Inc. - Overview
Exhibits119: IQVIA Holdings Inc. - Business segments
Exhibits120: IQVIA Holdings Inc. - Key news
Exhibits121: IQVIA Holdings Inc. - Key offerings
Exhibits122: IQVIA Holdings Inc. - Segment focus
Exhibits123: Laboratory Corp. of America Holdings - Overview
Exhibits124: Laboratory Corp. of America Holdings - Business segments
Exhibits125: Laboratory Corp. of America Holdings - Key news
Exhibits126: Laboratory Corp. of America Holdings - Key offerings
Exhibits127: Laboratory Corp. of America Holdings - Segment focus
Exhibits128: Medpace Holdings Inc. - Overview
Exhibits129: Medpace Holdings Inc. - Product / Service
Exhibits130: Medpace Holdings Inc. - Key offerings
Exhibits131: Parexel International Corp. - Overview
Exhibits132: Parexel International Corp. - Product / Service
Exhibits133: Parexel International Corp. - Key news
Exhibits134: Parexel International Corp. - Key offerings
Exhibits135: Pfizer Inc. - Overview
Exhibits136: Pfizer Inc. - Product / Service
Exhibits137: Pfizer Inc. - Key news
Exhibits138: Pfizer Inc. - Key offerings
Exhibits139: Sanofi - Overview
Exhibits140: Sanofi - Business segments
Exhibits141: Sanofi - Key news
Exhibits142: Sanofi - Key offerings
Exhibits143: Sanofi - Segment focus
Exhibits144: Syneos Health Inc. - Overview
Exhibits145: Syneos Health Inc. - Business segments
Exhibits146: Syneos Health Inc. - Key offerings
Exhibits147: Syneos Health Inc. - Segment focus
Exhibits148: Thermo Fisher Scientific Inc. - Overview
Exhibits149: Thermo Fisher Scientific Inc. - Business segments
Exhibits150: Thermo Fisher Scientific Inc. - Key news
Exhibits151: Thermo Fisher Scientific Inc. - Key offerings
Exhibits152: Thermo Fisher Scientific Inc. - Segment focus
Exhibits153: Inclusions checklist
Exhibits154: Exclusions checklist
Exhibits155: Currency conversion rates for US$
Exhibits156: Research methodology
Exhibits157: Validation techniques employed for market sizing
Exhibits158: Information sources
Exhibits159: List of abbreviations
